评估全关节置换术患者报告结局指标临床意义度量:一项系统综述
该系统综述纳入17项研究共44,935例患者,考察HOOS JR和KOOS JR的MCID、SCB和PASS推导方法与阈值。HOOS JR的分布法MCID为3.9至11.0分,锚定法MCID为14.8至38.1分;KOOS JR分别为4.0至8.7分和14.0至30.7分。作者认为各度量计算方法差异大,需标准化方法和使用。
要点
- HOOS JR的分布法MCID为3.9至11.0分,锚定法MCID为14.8至38.1分。
- KOOS JR的分布法MCID为4.0至8.7分,锚定法MCID为14.0至30.7分。
- MCID、SCB和PASS的计算方法存在较大差异,作者认为需标准化方法和使用。
核心结论
- MCID、SCB和PASS评分的计算方法存在较大差异,作者认为需标准化这些度量的计算方法和使用,以改善全关节置换术PROMs的评估。
研究设计与样本
- 系统综述,检索2000年至2025年关于HOOS JR和KOOS JR的文献,由两名评价者审核,纳入英文文献且针对初次全关节置换术推导MCID、SCB和/或PASS的研究,最终纳入17项研究共44,935例患者。
主要发现
- HOOS JR方面,10项研究推导分布法MCID(范围3.9至11.0分),6项研究推导锚定法MCID(范围14.8至38.1分),1项研究推导SCB(22分),3项研究推导PASS评分(范围73.5至81.0)。
- KOOS JR方面,9项研究推导分布法MCID(范围4.0至8.7分),6项研究推导锚定法MCID(范围14.0至30.7分),1项研究推导SCB(20分),2项研究推导PASS评分(范围63.7至71.0分)。
关键数值与推荐
- HOOS JR的分布法MCID范围为3.9至11.0分,锚定法MCID范围为14.8至38.1分,SCB为22分,PASS评分范围为73.5至81.0。
- KOOS JR的分布法MCID范围为4.0至8.7分,锚定法MCID范围为14.0至30.7分,SCB为20分,PASS评分范围为63.7至71.0。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recently, the Centers for Medicare and Medicaid Services mandated the collection of patient-reported outcome measures (PROMs) for all primary total joint arthroplasties (TJAs), reinforcing their role in evaluating clinical outcomes. This systematic review investigated the calculation methods and anchor questions used to derive key PROM-based thresholds such as Minimal Clinically Important Difference (MCID), substantial clinical benefit (SCB), and the patient acceptable symptom state (PASS) for the Hip Disability and Osteoarthritis Outcome Score for Joint Replacement (HOOS JR) and the Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS JR). METHODS: Databases were queried for articles from 2000 to 2025 specific to the HOOS JR and KOOS JR. Articles were reviewed by two reviewers and included if they were in the English language and derived either the MCID, SCB, and/or PASS metrics specific to primary total joint arthroplasty procedures. Study characteristics, MCID, SCB, and/or PASS thresholds, and methods of derivation were extracted. RESULTS: A total of 17 studies with 44,935 patients who met the final inclusion criteria were included. With respect to the HOOS JR, 10 studies derived a distribution-based MCID (range, 3.9 to 11.0 points), six studies derived an anchor-based MCID (range, 14.8 to 38.1 points), one study derived an SCB (22 points), and three studies derived a PASS score (range, 73.5 to 81.0). Specific to the KOOS JR, nine studies derived a distribution-based MCID (range, 4.0 to 8.7 points), six derived an anchor-based MCID (range, 14.0 to 30.7 points), one derived an SCB (20 points), and two derived a PASS score (range, 63.7 to 71.0 points). CONCLUSIONS: Substantial variability existed in the calculation methods reported for deriving the metrics specific to the MCID, SCB, and PASS scores. As such, it is imperative to standardize methodology and utilization for the calculation of MCIDs, SCB, and PASS metrics to allow for improved assessment of PROMs specific to total joint arthroplasty.
引用
- Finley CL, Gray CF, Parvataneni HK, et al. Evaluating Measures of Clinical Meaningfulness for Patient-Reported Outcome Measures in Total Joint Arthroplasty: A Systematic Review. J Arthroplasty. 2026. PMID: 41577304. doi:10.1016/j.arth.2026.01.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。